Guerbet announces financial calendar for 2026
Guerbet, a global specialist in contrast agents and solutions for medical imaging, has published its financial agenda for 2026. The calendar outlines dates for upcoming financial results publications and the annual shareholders' meeting.
Villepinte, France – November 19, 2025 – Guerbet, a global specialist in contrast agents and solutions for medical imaging, today announced its financial agenda for 2026. The company provided specific dates for its upcoming financial results and shareholder meetings throughout the year.
The 2025 annual revenue will be announced on February 05, 2026, followed by the 2025 annual results on March 11, 2026. The first quarter 2026 revenue figures are scheduled for release on April 23, 2026.
The annual shareholders’ meeting is set to take place on May 22, 2026. Guerbet will report its second quarter 2026 revenue on July 23, 2026, and its first half 2026 results on September 15, 2026. The third quarter 2026 revenue report is expected on October 22, 2026.
Guerbet is a key player in the medical imaging sector, offering a range of products including contrast agents, medical devices, and digital solutions. The company invests approximately 9% of its revenue in research and development and reported revenues of €841 million in 2024. With over 2,905 employees worldwide, Guerbet continues to focus on innovation in diagnostic and interventional imaging.